|
TCTN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.626032641866E-12 |
| Normal-vs-Stage2 |
7.237200E-03 |
| Normal-vs-Stage3 |
3.86110000000217E-05 |
| Normal-vs-Stage4 |
7.019700E-03 |
| Stage1-vs-Stage2 |
6.603600E-01 |
| Stage1-vs-Stage3 |
1.764520E-03 |
| Stage1-vs-Stage4 |
2.559900E-02 |
| Stage2-vs-Stage3 |
3.085200E-01 |
| Stage2-vs-Stage4 |
3.513200E-01 |
| Stage3-vs-Stage4 |
9.986200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81599180137937E-12 |
| Normal-vs-AfricanAmerican |
1.784600E-03 |
| Normal-vs-Asian |
1.200030E-03 |
| Caucasian-vs-AfricanAmerican |
7.247000E-01 |
| Caucasian-vs-Asian |
5.835200E-01 |
| AfricanAmerican-vs-Asian |
4.643400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.20830000000161E-06 |
| Normal-vs-Female |
1.626032641866E-12 |
| Male-vs-Female |
1.811050E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.88751269958721E-12 |
| Normal-vs-Age(41-60Yrs) |
1.72149999810856E-08 |
| Normal-vs-Age(61-80Yrs) |
1.956770E-04 |
| Normal-vs-Age(81-100Yrs) |
3.802600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.877800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.093800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.531800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.264800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.642200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.799800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.099100E-03 |
| Classical-VS-Follicular |
2.200600E-01 |
| Classical-VS-Other |
3.148600E-01 |
| Classical-VS-Normal |
1.25455201782643E-14 |
| Tall-VS-Follicular |
9.397800E-04 |
| Tall-VS-Other |
9.005000E-01 |
| Tall-VS-Normal |
1.456630E-01 |
| Follicular-VS-Other |
2.208800E-01 |
| Follicular-VS-Normal |
9.71189999532385E-08 |
| Other-VS-Normal |
4.352400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.19410078783744E-11 |
| Normal-vs-N1 |
1.041430E-03 |
| N0-vs-N1 |
5.218000E-01 |
|
|
